Kevin Lalande

Kevin Lalande is the managing director of Santé Ventures, a prominent life science venture capital firm he co-founded in 2006. Santé Ventures currently oversees $525 million in capital across three funds and specializes in creating and financing innovative healthcare and life science companies.

Throughout his career, Kevin has been instrumental in the success of several ventures, including LDR Medical (Zimmer Biomet), Explorys (IBM Corp), AbVitro (Celegene Corp), and others. His contributions have significantly impacted the industry.

In addition to his role at Santé Ventures, Kevin is the founder and chief investment officer of Santé Capital, a quantitative hedge fund that utilizes machine learning algorithms developed by Kevin himself. The fund commenced trading in 2015, showcasing Kevin's expertise in this area.

Before venturing into venture capital and hedge funds, Kevin gained valuable experience as a venture capitalist with Austin Ventures and as a management consultant with McKinsey & Company. His diverse background has equipped him with a unique skill set vital for success in the financial and healthcare sectors.

Kevin's educational background is equally impressive, holding a bachelor's degree with honors in Electrical & Computer Engineering, an MBA with highest distinction from Harvard Business School, and a graduate certificate in Artificial Intelligence from Stanford University. His academic achievements reflect his commitment to continuous learning and growth.

Kevin's specialties encompass venture capital, startups, healthcare, and AI/ML, showcasing his breadth of knowledge and experience in these high-demand areas of expertise.